Clinical Trials Logo

Clinical Trial Summary

Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated.

This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02147769
Study type Observational
Source Stanford University
Contact
Status Completed
Phase
Start date May 2014
Completion date March 2018

See also
  Status Clinical Trial Phase
Completed NCT05844709 - Effectiveness of Nursing Care Bundle for the Prevention of Intraventricular Hemorrhage in Preterm Infants
Active, not recruiting NCT02076373 - Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants Phase 3
Withdrawn NCT03390530 - Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage Phase 3
Terminated NCT01482559 - Management of Hypotension In the Preterm Infant Phase 3
Recruiting NCT06280872 - Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns N/A
Terminated NCT03543046 - Tortle Midliner and Intraventricular Hemorrhage N/A
Recruiting NCT05617833 - Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage Phase 1